Condition (MeSH)
Strongyloidiasis
ClinicalTrials.gov lists 15 trials for Strongyloidiasis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
15 of the 15 trials are tagged with Strongyloidiasis itself; the rest are tagged with a narrower condition beneath it.
When did Strongyloidiasis trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 2 |
| 2021 | 3 |
| 2018 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 1 |
| 2008 | 1 |
| 2005 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Strongyloidiasis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 7 |
| Not applicable | 2 |
| Observational | 5 |
How many Strongyloidiasis trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Completed | 10 |
| Terminated | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Strongyloidiasis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Centers for Disease Control and Prevention | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
Which drugs are being tested for Strongyloidiasis? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Ivermectin | 4 |
| Albendazole | 2 |
| Emodepside | 1 |
Interventions as named in the registry (11)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Azithromycin on Day 1 | 1 |
| IDA - Ivermectin + DEC + albendazole | 1 |
| Albendazole on Day 1 | 1 |
| Fixed-Dose Combination Albendazole/Ivermectin (FDC) | 1 |
| albendazole vs. combined albendazole/ivermectin treatment | 1 |
Showing 5 of 11 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Strongyloidiasis? (20)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 20 publications.
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Strongyloidiasis | Annual incidence | <1 / 1 000 000 | Spain | Not stated | Exact |
| Strongyloidiasis | Annual incidence | <1 / 1 000 000 | Spain | Not stated | Exact |
| Strongyloidiasis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Strongyloidiasis | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
| Strongyloidiasis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Strongyloidiasis | 76 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Strongyloidiasis | 76 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.